HMRC investment is a “missed opportunity to make a more significant difference”
Responding to Chancellor Jeremy Hunt’s Autumn Statement, President of the Association of Revenue and Customs – FDA’s section in HMRC – Loz Hutton welcomed “the Chancellor’s recognition of our members’ vital work in HMRC, to fund public services and support business.
“From creating a simpler, more effective tax system, to reducing the tax gap by giving HMRC greater power to tackle fraud, enabling further action against those promoting avoidance schemes, as well as increased investment in debt management capability.
Related News
-
Office attendance mandate “doesn’t make sense”, Crowley tells House of Lords Home-based Working Committee
FDA Assistant General Secretary Lauren Crowley gave oral evidence to the House of Lords Home-based Working Committee for its inquiry on remote and hybrid working.
-
78% of civil servants believe office attendance mandate has failed, finds new FDA report
A new report published by the FDA finds that the government’s 60% office attendance mandate has failed to deliver on any of its own objectives to boost productivity, improve collaboration, and help younger workers.
-
Scotland’s justice system needs ‘sustained further investment’
FDA National Officer Allan Sampson has warned that the “increase in funding and staffing” for the Crown Office and Procurator Fiscal Service (COPFS) “hasn’t been enough to tackle the long-term impact of a decade of underfunding dating back to 2010”.